PlainPharmaWatch

CMS Open Payments · Program Year 2024

Biocircuit Technologies Inc

Biocircuit Technologies Inc reported $69,755.19 across General Payments, Research, and Ownership to 112 physicians and teaching hospitals across 112 transactions.

See the rankings → How this is sourced
$69.8K
All-tracks total
112
Transactions
112
Recipients
#1271
of 1,925 companies

Biocircuit Technologies Inc reported $69,755.19 across all CMS Open Payments tracks (General + Research + Ownership) to 112 physicians and teaching hospitals in Program Year 2024 - ranking #1271 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $69,755.19, averaging $622.81 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer biocircuit-technologies-inc Biocircuit Technologies Inc

$69.8K · #1271/1,925 · 0.0% industry · PY2024

  • TOT $69.8K
  • RANK #1271
  • SHARE 0.0%
  • TXN 112
  • RCP 112
  • CAT 3
  • GEN $69.8K
  • TOP1 56.1%
  • PY 2024

Volume peers

Nearest volume peer: Coastal Medical Technologies Llc ($69.5K)

Servier Affaires Medicales$70.3KGrifols, S.A.$70.2KBiocircuit Technologies Inc …$69.8KCoastal Medical Technologies…$69.5KNexus CMF, LLC$69.0K
All-tracks payment totals near Biocircuit Technologies Inc (CMS Open Payments PY2024)

Biocircuit Technologies Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Biocircuit Technologies Inc

Averaging $622.81 per transaction and $622.81 per recipient, Biocircuit Technologies Inc's Program Year 2024 total comes to $69,755.19 across 112 transactions and 112 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #1271 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Consulting Fee" leads the 3-category general-payment breakdown below at $55.6K (79.8% of General Payments, 24 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Consulting Fee" leads Biocircuit Technologies Inc's 3-category general-payment breakdown at $55.6K, 79.8% of the reported total.

How Biocircuit Technologies Inc divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$55.6K2. Food and Beverage$8.0K3. Travel and Lodging$6.1K
Payment Type Amount Transactions
Consulting Fee $55.6K 24
Food and Beverage $8.0K 83
Travel and Lodging $6.1K 5

Recipient Concentration in General Payments

The five largest recipient relationships account for $61,741.13 (88.5%) of $69,755.19 in this company's General Payments records across 79 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Biocircuit Technologies Inc

The five named recipients with the highest reported General Payments from this company

Jonathan Isaacs$39.1KLisa Gfrerer$6.8KKyle Eberlin$6.5KSteven Moran$5.0KAlanna Rebecca$4.3K
  1. 1

    Jonathan Isaacs

    $39,148.67 across 16 reported transactions

  2. 2

    Lisa Gfrerer

    $6,817.28 across 4 reported transactions

  3. 3

    Kyle Eberlin

    $6,500.00 across 5 reported transactions

  4. 4

    Steven Moran

    $5,000.00 across 4 reported transactions

  5. 5

    Alanna Rebecca

    $4,275.18 across 7 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Biocircuit Technologies Inc's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Biocircuit Technologies Inc.

Organ Recovery Systems, Inc.

HHI 3422

American Rheumatology Network, LLC

HHI 3431

Granata Bio Corporation

HHI 3437

Collegium Pharmaceutical, Inc.

HHI 3442

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Biocircuit Technologies Inc.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Biocircuit Technologies Inc's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.